• #1030987
  • 40
  • Merck #00006404720

RotaTeq® Rotavirus Vaccine Indicated for Patients 6 to 32 Weeks of Age Solution Single Dose Tube 2 mL

ROTATEQ VAC, SUSP 2ML LIVE PENTAV (25/BX)

Features
  • RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1, G2, G3, G4, and G9
  • RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • More …
  Log In to Order
or

Product Specifications


Features
  • RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1, G2, G3, G4, and G9
  • RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
  • The dosing tube is contained in a pouch
  • Package of 25 individually pouched single-dose tubes
More Information

Professionals Also Viewed